Latest Innovation News

AdNeo Limited’s shares are back on the ASX following the completion of a capital raising, ending a trading suspension that had investors waiting. The biotech company’s next moves will be closely watched as it seeks to leverage fresh funds.

AdNeo Limited has completed a $5.5 million equity placement and announced a transformational acquisition of Learnt Global, doubling its revenue and significantly reducing debt to position itself as a leader in Australia’s vocational education technology sector.

Opyl Limited has secured strategic collaborations with two leading contract research organisations, integrating its AI-driven TrialKey platform into cardiovascular, oncology, and rare disease clinical trials to enhance trial design and accelerate commercial growth.

ASX Limited reveals steady progress on its FY28 strategy, emphasizing technology modernization and operational resilience while providing detailed financial guidance through FY27.

Cleo Diagnostics unveils a pioneering blood test for early ovarian cancer detection, boasting superior accuracy to existing methods and targeting a significant U.S. market opportunity.

Brazilian Rare Earths has successfully produced high-purity mixed-rare-earth carbonate and uranium yellowcake from its Monte Alto Project, marking a key milestone in its integrated supply chain ambitions.

Vulcan Energy has extended its conditional debt commitment letter to September 2025, aligning with its revised financing timeline for the Lionheart Project. This move supports ongoing bank discussions and the potential inclusion of significant government funding.

Nanoveu Limited has locked in a $500,000 funding guarantee through an options underwriting agreement, underpinning its push to commercialise cutting-edge semiconductor and 3D visualisation technologies.

Talga Group has cleared the last regulatory hurdle for its Nunasvaara South graphite mine in Sweden, paving the way for production of battery anode materials critical to the green transition.

Lindian Resources has secured a combined $1.65 million cash inflow from the exercise of unlisted options and a government R&D tax refund, strengthening its financial position for advancing the Kangankunde Rare Earths Project.

Telix Pharmaceuticals showcased its global theranostic radiopharmaceutical portfolio, highlighting FDA approvals, clinical progress, and a robust commercial expansion plan at its 2025 Investor Day.

DigitalX Limited's treasury reached a record A$75.9 million in May 2025, propelled by increased Solana holdings and enhanced staking yields. The company’s innovative approach balances Bitcoin’s stability with yield-generating digital assets.